Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Long-Term Deferred Tax (2022 - 2023)

Historic Long-Term Deferred Tax for Envoy Medical (COCH) over the last 2 years, with Q4 2023 value amounting to $50.2 million.

  • Envoy Medical's Long-Term Deferred Tax rose 1308.03% to $50.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $50.2 million, marking a year-over-year increase of 1308.03%. This contributed to the annual value of $50.2 million for FY2023, which is 1308.03% up from last year.
  • According to the latest figures from Q4 2023, Envoy Medical's Long-Term Deferred Tax is $50.2 million, which was up 1308.03% from $44.4 million recorded in Q4 2022.
  • Envoy Medical's Long-Term Deferred Tax's 5-year high stood at $50.2 million during Q4 2023, with a 5-year trough of $44.4 million in Q4 2022.